Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-04-11 @ 10:59 PM
Study NCT ID:
NCT00251251
Status:
COMPLETED
Last Update Posted:
2023-08-28
First Post:
2005-11-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial
Sponsor:
Ottawa Heart Institute Research Corporation
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Heart Failure, Congestive | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Multicentre randomized controlled trial | View |
| None | Defibrillator | View |
| None | Cardiac resynchronization | View |
| None | Sudden death/mortality | View |
| None | Hospitalization | View |
| None | ICD indication | View |
| None | NYHA Class II | View |
| None | LVEF </equal to 30% | View |
| None | QRS >/equal to 120 ms | View |
| None | Congestive heart failure | View |